Phibro Animal Health Corp (PAHC) Given Average Recommendation of “Hold” by Brokerages

Phibro Animal Health Corp (NASDAQ:PAHC) has been assigned an average recommendation of “Hold” from the six analysts that are presently covering the stock, Marketbeat.com reports. Two research analysts have rated the stock with a sell recommendation and four have given a hold recommendation to the company. The average twelve-month target price among analysts that have updated their coverage on the stock in the last year is $40.33.

PAHC has been the topic of a number of research analyst reports. BidaskClub downgraded Phibro Animal Health from a “hold” rating to a “sell” rating in a report on Tuesday, September 18th. Zacks Investment Research downgraded Phibro Animal Health from a “hold” rating to a “strong sell” rating in a report on Wednesday, October 24th. Finally, ValuEngine downgraded Phibro Animal Health from a “buy” rating to a “hold” rating in a report on Monday, November 12th.

Shares of PAHC stock opened at $33.11 on Friday. Phibro Animal Health has a 1-year low of $30.79 and a 1-year high of $54.62. The company has a current ratio of 3.26, a quick ratio of 1.82 and a debt-to-equity ratio of 1.62. The firm has a market cap of $1.33 billion, a PE ratio of 19.03, a price-to-earnings-growth ratio of 3.32 and a beta of 0.75.

Phibro Animal Health (NASDAQ:PAHC) last issued its quarterly earnings results on Tuesday, November 6th. The company reported $0.39 earnings per share for the quarter, missing analysts’ consensus estimates of $0.42 by ($0.03). Phibro Animal Health had a net margin of 7.89% and a return on equity of 38.91%. The business had revenue of $200.20 million for the quarter, compared to analysts’ expectations of $203.99 million. During the same quarter in the prior year, the firm posted $0.38 EPS. The business’s quarterly revenue was up 3.5% compared to the same quarter last year. On average, equities research analysts anticipate that Phibro Animal Health will post 1.71 EPS for the current year.

The firm also recently declared a quarterly dividend, which was paid on Wednesday, December 19th. Stockholders of record on Wednesday, November 28th were issued a dividend of $0.12 per share. This is an increase from Phibro Animal Health’s previous quarterly dividend of $0.10. The ex-dividend date was Tuesday, November 27th. This represents a $0.48 dividend on an annualized basis and a dividend yield of 1.45%. Phibro Animal Health’s payout ratio is currently 27.59%.

In other Phibro Animal Health news, insider Dean J. Warras sold 10,000 shares of the business’s stock in a transaction dated Thursday, November 1st. The stock was sold at an average price of $42.84, for a total value of $428,400.00. Following the transaction, the insider now owns 10,000 shares in the company, valued at $428,400. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, VP Daniel M. Bendheim sold 5,000 shares of the business’s stock in a transaction dated Wednesday, January 9th. The shares were sold at an average price of $32.43, for a total value of $162,150.00. Following the completion of the transaction, the vice president now owns 2,500 shares in the company, valued at approximately $81,075. The disclosure for this sale can be found here. Insiders have sold 20,000 shares of company stock worth $750,375 in the last quarter. 50.29% of the stock is currently owned by corporate insiders.

A number of hedge funds and other institutional investors have recently modified their holdings of the business. FMR LLC grew its stake in Phibro Animal Health by 0.7% in the second quarter. FMR LLC now owns 171,107 shares of the company’s stock valued at $7,879,000 after purchasing an additional 1,109 shares in the last quarter. Macquarie Group Ltd. grew its stake in Phibro Animal Health by 16.3% in the second quarter. Macquarie Group Ltd. now owns 9,998 shares of the company’s stock valued at $460,000 after purchasing an additional 1,400 shares in the last quarter. Meeder Asset Management Inc. grew its stake in Phibro Animal Health by 34.9% in the third quarter. Meeder Asset Management Inc. now owns 6,028 shares of the company’s stock valued at $258,000 after purchasing an additional 1,558 shares in the last quarter. Victory Capital Management Inc. grew its stake in Phibro Animal Health by 27.7% in the third quarter. Victory Capital Management Inc. now owns 10,337 shares of the company’s stock valued at $443,000 after purchasing an additional 2,242 shares in the last quarter. Finally, Alliancebernstein L.P. boosted its stake in shares of Phibro Animal Health by 3.8% during the 3rd quarter. Alliancebernstein L.P. now owns 65,520 shares of the company’s stock worth $2,811,000 after acquiring an additional 2,400 shares in the last quarter. Hedge funds and other institutional investors own 49.62% of the company’s stock.

About Phibro Animal Health

Phibro Animal Health Corporation operates as a diversified animal health and mineral nutrition company primarily in the United States. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for a range of food animals, including poultry, swine, beef and dairy cattle, and aquaculture.

Further Reading: What is the Quick Ratio?

Receive News & Ratings for Phibro Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply